In The Third Year Of The Pandemic And As Americans Grapple With Record Inflation, Big Pharma Continues To Raise Prices And Exploit Patients

This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.

Drug companies raised the prices of 742 drugs in January 2022

P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.

Pharmaceutical Industry’s Financial Power And Influence Remain Strong And Far-Reaching As Drug Pricing Legislation Moves Forward